Covered recipient · General Payments record
CLAUD LAWRENCE HORN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2020–2025
$740.59
- Reported across 53 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $230.43 | 19 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $163.64 | 16 |
| Axsome Therapeutics, Inc. | $31.59 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.13 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.64 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065404 | CMS |
| ABBVIE INC. | $11.69 | 02/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065406 | CMS |
| ABBVIE INC. | $17.25 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065408 | CMS |
| ABBVIE INC. | $12.73 | 03/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065410 | CMS |
| ABBVIE INC. | $7.23 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065412 | CMS |
| ABBVIE INC. | $13.63 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065414 | CMS |
| ABBVIE INC. | $8.18 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065416 | CMS |
| ABBVIE INC. | $15.54 | 04/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065418 | CMS |
| ABBVIE INC. | $12.71 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065420 | CMS |
| ABBVIE INC. | $9.76 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065422 | CMS |
| ABBVIE INC. | $12.16 | 07/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065424 | CMS |
| ABBVIE INC. | $9.83 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065426 | CMS |
| ABBVIE INC. | $7.87 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065428 | CMS |
| ABBVIE INC. | $7.23 | 08/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065430 | CMS |
| ABBVIE INC. | $8.58 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065432 | CMS |
| ABBVIE INC. | $4.61 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202065434 | CMS |
| Axsome Therapeutics, Inc. | $31.59 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235520415 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.07 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227352251 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.13 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223841748 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.